Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPotent and selective farnesyl transferase inhibitor (IC50 = 1.35 nM). 1000-fold selective over GGT1 enzyme. Exhibits anti-tumour activity in vivo following oral administration.
Sold with the permission of Bristol-Myers Squibb Company, subject to U.S. Patent No. 6,011,029 and other US and foreign patents.
分子量 | 489.61 |
储存 | Desiccate at RT |
纯度 | ≥99% (HPLC) |
CAS Number | 195987-41-8 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Hunt et al (2000) Discovery of (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumour activity. J.Med.Chem. 43 3587 PMID: 11020273
Owa et al (2001) Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr.Med.Chem. 8 1487 PMID: 11562278
Rose et al (2001) Preclinical antitumour activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor. Cancer Res. 61 7507 PMID: 11606387
关键词: BMS 214662, BMS 214662 supplier, Other, Transferases, Post-translational, Modifications, 1444, Tocris Bioscience
目前没有该产品的评论。 Be the first to review BMS 214662 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image